Join us in February 2026, for essential insights into navigating AI’s legal and regulatory landscape in life sciences. Discover how AI is accelerating drug discovery, optimizing clinical trials, and enhancing disease diagnosis to bridge innovation with real-world healthcare.
Advisory Board
Learn more about ACI’s Life Science AI Advisory Board, who counsels the ACI team on the impact of legal, regulatory, and compliance trends and emerging topics in the evolving life science arena.
What You Will Walk Away With
A deep understanding of the legal, regulatory, compliance, and ethical concerns related to the use of AI, ML and data analytics in life sciences
Real-world case studies and examples of best practices for addressing potential challenges that come with AI
The opportunity to engage in discussions with industry thought leaders and peers from across the country to share knowledge, solutions, and ideas
An expanded professional network and valuable connections
How Can Companies Tackle Europe’s AI and Data Protection Rules?
Life science companies will have to grapple with unique questions in complying with the European Artificial Intelligence Act, including the scope of the law’s research exemption and the use of AI in personalized medicine and real world-evidence.
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]